AZN icon

AstraZeneca

1,138 hedge funds and large institutions have $33.8B invested in AstraZeneca in 2024 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 485 increasing their positions, 340 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0.45% less ownership

Funds ownership: 32.57%32.12% (-0.45%)

1% less capital invested

Capital invested by funds: $34B → $33.8B (-$235M)

8% less funds holding in top 10

Funds holding in top 10: 1312 (-1)

Holders
1,138
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$480M
Puts
$470M
Net Calls
Net Calls Change

Top Sellers

1 -$903M
2 -$659M
3 -$157M
4
N
Nuveen
North Carolina
-$129M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$103M
Name Holding Trade Value Shares
Change
Change in
Stake
251
$4.05M
252
$4.04M
253
$4.03M
254
$4.02M
255
$4.02M
256
$4.02M
257
$4.01M
258
$3.98M
259
$3.82M
260
$3.77M
261
$3.74M
262
$3.74M
263
$3.73M
264
$3.71M
265
$3.68M
266
$3.65M
267
$3.64M
268
$3.62M
269
$3.61M
270
$3.61M
271
$3.59M
272
$3.56M
273
$3.54M
274
$3.45M
275
$3.44M